Home	Fast Track My Amedeo FAQ About	Flying Publisher
Fast Track	Free PDFs: Hepatology 2013 (574 pages) – Hepatitis C 2013 Amedeo Smart: the Smartphone Edition	Free Abstracts

Malignant Melanoma

Free Subscription Articles published in Br J Dermatol Retrieve available abstracts of 99 articles: HTML format Text format

Single Articles

May 2013
1. PICARD A , Tsilika K, Long-Mira E, Hofman P, et al
   Interest of High Definition Optical Coherent Tomography (HD-OCT) for imaging of melanoma.
   Br J Dermatol. 2013 May 11. doi: 10.1111/bjd.12433.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
2. GONZALEZ-HERRERO I , Romero-Camarero I, Canueto J, Cardenoso-Alvarez E, et al
   The CD133 cell content correlates with tumor growth in melanomas from skin with chronic sun-induced damage.
   Br J Dermatol. 2013 May 11. doi: 10.1111/bjd.12428.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
3. LADE-KELLER J , Riber-Hansen R, Guldberg P, Schmidt H, et al
   E- to N-cadherin switch in melanoma is associated with decreased expression of PTEN and cancer progression.
   Br J Dermatol. 2013 May 11. doi: 10.1111/bjd.12426.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
4. CAZENAVE H , Maubec E, Mohamdi H, Grange F, et al
   Anorectal and genital mucosal melanoma is associated with cutaneous melanoma in patients and in families.
   Br J Dermatol. 2013 May 6. doi: 10.1111/bjd.12421.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
5. PUIG-BUTILLE JA , Carrera C, Kumar R, Garcia-Casado Z, et al
   Distribution of MC1R variants among melanoma subtypes: p.R163Q is associated with Lentigo Maligna Melanoma in a Mediterranean population.
   Br J Dermatol. 2013 May 6. doi: 10.1111/bjd.12418.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
6. VAN DER LEEST RJ , Nijsten T, de Vries E
   Screening for second primary melanomas: is it efficient? Reply from authors.
   Br J Dermatol. 2013;168:1135.
   PubMed     Text format     Related articles   
   
   
   
   
7. GEURTS SM , van Dijck JA, Bonenkamp JJ, Soetekouw PM, et al
   Screening for second primary melanomas: is it efficient?
   Br J Dermatol. 2013;168:1133-5.
   PubMed     Text format     Related articles   
   
   
   
   April 2013
8. STANGANELLI I , Gandini S, Magi S, Mazzoni L, et al
   Sunbed use among subjects at high risk for melanoma: an Italian survey after the ban.
   Br J Dermatol. 2013 Apr 19. doi: 10.1111/bjd.12384.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
9. SCHLAAK M , Bajah A, Podewski T, Kreuzberg N, et al
   Assessment of clinical parameters associated with mutational status in metastatic malignant melanoma: a single-centre investigation of 141 patients.
   Br J Dermatol. 2013;168:708-16.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
10. WHITEMAN DC
    Prognostic sub-classifications of T1 cutaneous melanomas based on ulceration, tumour thickness and Clark level of invasion. Results of a population-based study from the Swedish Melanoma Register.
    Br J Dermatol. 2013;168:685-6.
    PubMed     Text format     Related articles   
    
    
    
    
11. SAFAEE ARDEKANI G , Jafarnejad SM, Khosravi S, Martinka M, et al
    Disease Progression and Patient Survival Are Significantly Influenced by BRAF Protein Expression in Primary Melanoma.
    Br J Dermatol. 2013 Apr 1. doi: 10.1111/bjd.12351.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    March 2013
12. HOLTERHUES C , Hollestein LM, Nijsten T, Koomen ER, et al
    Burden of disease due to cutaneous melanoma increased in the Netherlands since 1991.
    Br J Dermatol. 2013 Mar 29. doi: 10.1111/bjd.12346.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
13. GYLLENCREUTZ JD , Bostrom KB, Terstappen K
    Does it look like melanoma? A pilot study of the effect of sunless tanning on dermoscopy of pigmented skin lesions.
    Br J Dermatol. 2013 Mar 18. doi: 10.1111/bjd.12194.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
14. COSTA J , Ortiz-Ibanez K, Salerni G, Borges V, et al
    Dermoscopic patterns of Melanoma Metastases: inter-observer consistency and accuracy for metastases recognition.
    Br J Dermatol. 2013 Mar 18. doi: 10.1111/bjd.12314.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
15. TSIANAKAS A , Bohm MR, Getova V, Metze D, et al
    Skin metastases in metastatic uveal melanoma - GNAQ / GNA11 mutational analysis as a valuable tool.
    Br J Dermatol. 2013 Mar 6. doi: 10.1111/bjd.12291.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
16. GOLDSMITH SM
    Increased emphasis on darkness and rejection of a diameter criterion represent paradigm shifts in the clinical diagnosis of melanoma.
    Br J Dermatol. 2013 Mar 6. doi: 10.1111/bjd.12301.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
17. HUNTER HL , Dolan OM, McMullen E, Donnelly D, et al
    Incidence and survival in patients with cutaneous malignant melanoma: experience in a U.K. population, 1984-2009.
    Br J Dermatol. 2013;168:676-8.
    PubMed     Text format     Related articles   
    
    
    
    
18. MARPLES M
    Commentary: BRAF inhibitors for metastatic melanoma.
    Br J Dermatol. 2013;168:471-3.
    PubMed     Text format     Related articles   
    
    
    
    
19. HAUSCHILD A
    Response to a costly revolution for a subgroup of patients with metastatic melanoma.
    Br J Dermatol. 2013;168:470-1.
    PubMed     Text format     Related articles   
    
    
    
    
20. VAN AKKOOI AC , Nijsten T
    A costly revolution for a subgroup of patients with metastatic melanoma.
    Br J Dermatol. 2013;168:467-70.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    February 2013
21. RAPANOTTI M , Ricozzi I, Campione E, Orlandi A, et al
    Blood MUC-18/MCAM expression in melanoma patients: a suitable marker of poor outcome.
    Br J Dermatol. 2013 Feb 28. doi: 10.1111/bjd.12295.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
22. LENORMAND C , Cribier B, Lipsker D
    Eruptive pigmentation around naevi and seborrhoeic keratoses in a patient with stage III melanoma: hyperpigmented halo or 'Nottus' phenomenon.
    Br J Dermatol. 2013 Feb 27. doi: 10.1111/bjd.12165.
    PubMed     Text format     Related articles   
    
    
    
    
23. TEULINGS HE , Tjin EP, Willemsen KJ, Krebbers G, et al
    Radiation induced melanoma-associated-leukoderma, systemic anti-melanoma immunity and disease-free survival in an advanced-stage melanoma patient: A case report and immunological analysis.
    Br J Dermatol. 2013 Feb 19. doi: 10.1111/bjd.12136.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
24. MOSCARELLA E , Rabinovitz H, Puig S, Zalaudek I, et al
    Multiple primary melanomas: do they look the same ?
    Br J Dermatol. 2013 Feb 3. doi: 10.1111/bjd.12260.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
25. OH BH , Lee SH, Nam KA, Lee HB, et al
    Comparison of negative pressure wound therapy and secondary intention healing after excision of acral lentiginous melanoma on the foot.
    Br J Dermatol. 2013;168:333-8.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    January 2013
26. GONZALEZ D , Fearfield L, Nathan P, Taniere P, et al
    BRAF mutation testing algorithm for vemurafenib treatment in melanoma: recommendations from an expert panel.
    Br J Dermatol. 2013 Jan 29. doi: 10.1111/bjd.12248.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
27. DEBARBIEUX S , Dalle S, Depaepe L, Poulalhon N, et al
    Second primary melanomas under BRAF blockers: study by Reflectance Confocal Microscopy.
    Br J Dermatol. 2013 Jan 10. doi: 10.1111/bjd.12210.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
28. MUN JH , Kim GW, Jwa SW, Song M, et al
    Dermoscopy of subungual haemorrhage: Its usefulness in the differential diagnosis from nail unit melanoma.
    Br J Dermatol. 2013 Jan 10. doi: 10.1111/bjd.12209.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
29. SULLIVAN R
    The challenge of developing useful blood-based biomarkers in melanoma.
    Br J Dermatol. 2013;168:3.
    PubMed     Text format     Related articles   
    
    
    
    December 2012
30. SAIAG P
    Toward a new place for dermatologists in the diagnosis of melanoma in France?
    Br J Dermatol. 2012;167:1199.
    PubMed     Text format     Related articles   
    
    
    
    November 2012
31. TEULINGS HE , Overkamp M, Ceylan E, Nieuweboer-Krobotova L, et al
    Decreased risk of melanoma and nonmelanoma skin cancer in patients with vitiligo: a survey among 1307 patients and their partners.
    Br J Dermatol. 2012 Nov 9. doi: 10.1111/bjd.12111.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
32. BOCKLE BC , Stanarevic G, Ratzinger G, Sepp NT, et al
    Analysis of 303 Ro/SS-A antibody-positive patients: is this antibody a possible marker for malignancy?
    Br J Dermatol. 2012;167:1067-75.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    October 2012
33. VAN DER VORST JR , Schaafsma BE, Verbeek FP, Swijnenburg RJ, et al
    Dose Optimization for Near-Infrared Fluorescence Sentinel Lymph Node Mapping in Melanoma Patients.
    Br J Dermatol. 2012 Oct 18. doi: 10.1111/bjd.12059.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
34. LYTH J , Hansson J, Ingvar C, Mansson-Brahme E, et al
    Prognostic sub-classifications of T1 cutaneous melanomas based on ulceration, tumour thickness and Clark's level of invasion. Results of a population-based study from the Swedish Melanoma Register.
    Br J Dermatol. 2012 Oct 15. doi: 10.1111/bjd.12095.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
35. FEARFIELD L , Newton-Bishop JA, Sinha R, Edmonds K, et al
    Second perimary melanomas under vemurafenib - reply from the author.
    Br J Dermatol. 2012 Oct 15. doi: 10.1111/bjd.12094.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
36. DALLE S , Poulalhon N, Debarbieux S, Thomas L, et al
    Second primary melanomas under vemurafenib.
    Br J Dermatol. 2012 Oct 15. doi: 10.1111/bjd.12093.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    September 2012
37. GRANT WB
    Disparities in melanoma incidence rates in Europe.
    Br J Dermatol. 2012 Sep 26. doi: 10.1111/bjd.12054.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
38. IDORN LW , Datta P, Heydenreich J, Philipsen PA, et al
    Sun behaviour after cutaneous malignant melanoma A study based on ultraviolet radiation measurements and sun diary data.
    Br J Dermatol. 2012 Sep 26. doi: 10.1111/bjd.12066.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
39. REID AL , Millward M, Pearce R, Lee M, et al
    Markers of circulating tumour cells in the peripheral blood of melanoma patients correlates with disease recurrence and progression.
    Br J Dermatol. 2012 Sep 26. doi: 10.1111/bjd.12057.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
40. DE GIORGI V , Gori A, Gandini S, Papi F, et al
    Estrogen receptor beta and melanoma. A comparative study.
    Br J Dermatol. 2012 Sep 26. doi: 10.1111/bjd.12056.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    August 2012
41. SINHA R , Edmonds K, Newton-Bishop JA, Gore ME, et al
    Cutaneous adverse events associated with vemurafenib in patients with metastatic melanoma: practical advice on diagnosis, prevention and management of the main treatment-related skin toxicities.
    Br J Dermatol. 2012 Aug 22. doi: 10.1111/bjd.12010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
42. TITUS LJ , Clough-Gorr K, Mackenzie TA, Perry A, et al
    Recent Skin Self-Examination and Doctor Visits in Relation to Melanoma Risk and Tumor Depth.
    Br J Dermatol. 2012 Aug 16. doi: 10.1111/bjd.12003.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
43. GAMBICHLER T , Bindsteiner M, Hoxtermann S, Kreuter A, et al
    Serum 25-hydroxyvitamin D serum levels in a large German cohort of melanoma patients.
    Br J Dermatol. 2012 Aug 9. doi: 10.1111/j.1365-2133.2012.11212.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
44. STRATIGOS AJ , Forsea AM, van der Leest RJ, de Vries E, et al
    Euromelanoma: a dermatology-led European campaign against nonmelanoma skin cancer and cutaneous melanoma. Past, present and future.
    Br J Dermatol. 2012;167 Suppl 2:99-104.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
45. DE VRIES E , Arnold M, Altsitsiadis E, Trakatelli M, et al
    Potential impact of interventions resulting in reduced exposure to ultraviolet (UV) radiation (UVA and UVB) on skin cancer incidence in four European countries, 2010-2050.
    Br J Dermatol. 2012;167 Suppl 2:53-62.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
46. DE VRIES E , Trakatelli M, Kalabalikis D, Ferrandiz L, et al
    Known and potential new risk factors for skin cancer in European populations: a multicentre case-control study.
    Br J Dermatol. 2012;167 Suppl 2:1-13.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    July 2012
47. GRANGE F , Barbe C, Mas L, Granel-Brocard F, et al
    The role of general practitioners in diagnosis of cutaneous melanoma: a population-based study in France.
    Br J Dermatol. 2012 Jul 27. doi: 10.1111/j.1365-2133.2012.11178.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
48. ANFORTH RM , Blumetti TC, Kefford RF, Sharma R, et al
    Cutaneous Manifestations of Dabrafenib (GSK2118436): A Selective Inhibitor of Mutant BRAF in patients with Metastatic Melanoma.
    Br J Dermatol. 2012 Jul 16. doi: 10.1111/j.1365-2133.2012.11155.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
49. RICHTIG E , Schrama D, Ugurel S, Fried I, et al
    BRAF mutation analysis of only one single metastatic lesion can restrict the treatment of melanoma - a case report.
    Br J Dermatol. 2012 Jul 7. doi: 10.1111/j.1365-2133.2012.11121.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
50. ROBSON Y , Blackford S, Roberts D
    Caution in melanoma risk analysis with smartphone application technology.
    Br J Dermatol. 2012 Jul 5. doi: 10.1111/j.1365-2133.2012.11046.
    PubMed     Text format     Related articles   
    
    
    
    
51. LUTTRELL MJ , McClenahan P, Hofmann-Wellenhof R, Fink-Puches R, et al
    Laypersons' sensitivity for melanoma identification is higher with dermoscopy images than clinical photographs.
    Br J Dermatol. 2012 Jul 4. doi: 10.1111/j.1365-2133.2012.11130.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
52. FORSEA AM , Del Marmol V, de Vries E, Bailey EE, et al
    Melanoma incidence and mortality in Europe: new estimates, persistent disparities.
    Br J Dermatol. 2012 Jul 3. doi: 10.1111/j.1365-2133.2012.11125.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
53. VAN DER LEEST RJ , Liu L, Coebergh JW, Neumann HA, et al
    Risk of second primary in situ and invasive melanoma in Dutch population-based cohort: 1989 - 2008.
    Br J Dermatol. 2012 Jul 3. doi: 10.1111/j.1365-2133.2012.11123.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    June 2012
54. JUNG GW , Weinstock MA
    Clinicopathologic comparisons of index and second primary melanomas in pediatric and adult populations.
    Br J Dermatol. 2012 Jun 20. doi: 10.1111/j.1365-2133.2012.11097.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
55. DEBARBIEUX S , Hospod V, Depaepe L, Balme B, et al
    Peroperative confocal microscopy of the nail matrix in the management of in situ or minimally invasive subungual melanomas.
    Br J Dermatol. 2012 Jun 7. doi: 10.1111/j.1365-2133.2012.11013.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
56. STURM RA
    GSTP1 and MC1R in melanoma susceptibility.
    Br J Dermatol. 2012;166:1155-6.
    PubMed     Text format     Related articles   
    
    
    
    May 2012
57. YOUL PH , Youlden DR, Baade PD
    Changes in the site distribution of common melanoma sub-types in Queensland, Australia over time: implications for public health campaigns.
    Br J Dermatol. 2012 May 21. doi: 10.1111/j.1365-2133.2012.11064.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
58. MILLINGTON GW
    Leptin, obesity and cutaneous melanoma.
    Br J Dermatol. 2012 May 14. doi: 10.1111/j.1365-2133.2012.10757.
    PubMed     Text format     Related articles   
    
    
    
    
59. TROMME I , Sacre L, Hammouch F, Legrand C, et al
    Availability of digital dermoscopy in daily practice dramatically reduces the number of excised melanocytic lesions: results from an observational study.
    Br J Dermatol. 2012 May 7. doi: 10.1111/j.1365-2133.2012.11042.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
60. EISEMANN N , Jansen L, Holleczek B, Waldmann A, et al
    Up-to-date survival of melanoma patients in Germany.
    Br J Dermatol. 2012 May 5. doi: 10.1111/j.1365-2133.2012.11039.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    April 2012
61. NAGEL G , Bjorge T, Stocks T, Manjer J, et al
    Metabolic risk factors and skin cancer in the Metabolic Syndrome and Cancer Project (Me-Can).
    Br J Dermatol. 2012 Apr 24. doi: 10.1111/j.1365-2133.2012.10974.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
62. LOVE PB , Nelson KC
    Melanoma of the hand and foot: a distinct clinical variant of cutaneous melanoma.
    Br J Dermatol. 2012;166:708.
    PubMed     Text format     Related articles   
    
    
    
    March 2012
63. MOSCARELLA E , Zalaudek I, Cerroni L, Sperduti I, et al
    Excised melanocytic lesions in children and adolescents: A ten-year survey.
    Br J Dermatol. 2012 Mar 19. doi: 10.1111/j.1365-2133.2012.10952.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
64. PRALONG P , Bathelier E, Dalle S, Poulalhon N, et al
    Dermoscopy of Lentigo Maligna Melanoma: Report of 125 Cases.
    Br J Dermatol. 2012 Mar 8. doi: 10.1111/j.1365-2133.2012.10932.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    February 2012
65. HAO L , Ha JR, Kuzel P, Garcia E, et al
    Cadherin Switch from E- to N-Cadherin in Melanoma Progression is regulated by the PI3K/PTEN Pathway through TWIST and SNAIL.
    Br J Dermatol. 2012 Feb 14. doi: 10.1111/j.1365-2133.2012.10824.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    January 2012
66. TAKEI Y , Huynh KT, Kuo C, Scolyer RA, et al
    Aberrant Hypermethylation in Primary and Sentinel Lymph Node Metastases in Pediatric Cutaneous Melanoma Patients.
    Br J Dermatol. 2012 Jan 31. doi: 10.1111/j.1365-2133.2012.10867.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
67. BALOGH K , Szell M, Polyanka H, Pagani F, et al
    Detection of a rare CDKN2A intronic mutation in a Hungarian melanoma-prone family and its role in splicing regulation.
    Br J Dermatol. 2012 Jan 31. doi: 10.1111/j.1365-2133.2012.10864.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
68. TERUSHKIN V , Dusza SW, Scope A, Argenziano G, et al
    Changes observed in slow growing melanomas during long-term dermoscopic monitoring.
    Br J Dermatol. 2012 Jan 27. doi: 10.1111/j.1365-2133.2012.10846.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
69. IBARROLA-VILLAVA M , Martin-Gonzalez M, Lazaro P, Pizarro A, et al
    Role of GSTs in Melanoma Susceptibility: Association with rs1695 GSTP1 Polymorphism.
    Br J Dermatol. 2012 Jan 17. doi: 10.1111/j.1365-2133.2012.10831.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
70. LOMAS A , Leonardi-Bee J, Bath-Hextall F
    A Systematic Review of worldwide incidence of Non-melanoma skin cancer.
    Br J Dermatol. 2012 Jan 17. doi: 10.1111/j.1365-2133.2012.10830.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    December 2011
71. DURBEC F , Martin L, Derancourt C, Grange F, et al
    Melanoma of the hand and foot Epidemiologic, prognostic and genetic features: a systematic review.
    Br J Dermatol. 2011 Dec 17. doi: 10.1111/j.1365-2133.2011.10772.
    PubMed     Text format     Related articles   
    
    
    
    
72. LEE HJ , Park MK, Kim SY, Park Choo HY, et al
    Serotonin induces melanogenesis via serotonin receptor 2A.
    Br J Dermatol. 2011;165:1344-8.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    November 2011
73. MILLINGTON GW
    Leptin, Obesity and Cutaneous Melanoma.
    Br J Dermatol. 2011 Nov 28. doi: 10.1111/j.1365-2133.2011.10757.
    PubMed     Text format     Related articles   
    
    
    
    
74. DE GIORGI V , Gori A, Grazzini M, Rossari S, et al
    Obesity and Melanoma.
    Br J Dermatol. 2011 Nov 19. doi: 10.1111/j.1365-2133.2011.10752.
    PubMed     Text format     Related articles   
    
    
    
    October 2011
75. LEVELL NJ
    English melanoma by body site: keep wearing the trousers?
    Br J Dermatol. 2011;165:709-10.
    PubMed     Text format     Related articles   
    
    
    
    September 2011
76. POLOM K , Murawa D, Rho SY, Spychala A, et al
    Skin Melanoma Sentinel Lymph Node Biopsy Using Real Time Fluorescence Navigation With Indocyanine Green and Indocyanine Green With Human Serum Albumin.
    Br J Dermatol. 2011 Sep 16. doi: 10.1111/j.1365-2133.2011.10634.
    PubMed     Text format     Related articles   
    
    
    
    
77. GILES N , Pavey S, Pinder A, Gabrielli B, et al
    Multiple melanoma susceptibility factors function in a UVR response pathway in skin.
    Br J Dermatol. 2011 Sep 16. doi: 10.1111/j.1365-2133.2011.10635.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
78. YUN SJ , Kwon OS, Han JH, Kweon SS, et al
    Clinical Characteristics and Risk of Melanoma Development from Giant Congenital Melanocytic Naevi in Korea: A Nationwide Retrospective Study.
    Br J Dermatol. 2011 Sep 16. doi: 10.1111/j.1365-2133.2011.10636.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
79. ARGENZIANO G , Longo C, Cameron A, Cavicchini S, et al
    Blue-black rule: a simple dermoscopic clue to recognize pigmented nodular melanoma.
    Br J Dermatol. 2011 Sep 14. doi: 10.1111/j.1365-2133.2011.10621.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    August 2011
80. SUREDA N , Phan A, Poulalhon N, Balme B, et al
    Conservative surgical management of subungual (matrix derived) melanoma: report of seven cases and literature review.
    Br J Dermatol. 2011 Aug 4. doi: 10.1111/j.1365-2133.2011.10477.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
81. NIKOLAOU V , Kang X, Stratigos A, Gogas H, et al
    Comprehensive mutational analysis of CDKN2A and CDK4 in greek patients with cutaneous melanoma.
    Br J Dermatol. 2011 Aug 1. doi: 10.1111/j.1365-2133.2011.10551.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
82. LODEN M , Beitner H, Gonzalez H, Edstrom DW, et al
    Sunscreen use: controversies, challenges and regulatory aspects.
    Br J Dermatol. 2011;165:255-62.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    July 2011
83. SUPPA M , Elliott F, Mikeljevic JS, Mukasa Y, et al
    The determinants of periorbital skin aging in participants of a melanoma case control study in the UK.
    Br J Dermatol. 2011 Jul 23. doi: 10.1111/j.1365-2133.2011.10536.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
84. DIFFEY BL
    In praise of small studies.
    Br J Dermatol. 2011;165:3-4.
    PubMed     Text format     Related articles   
    
    
    
    June 2011
85. FEITO-RODRIGUEZ M , de Lucas-Laguna R, Bastian BC, Leboit P, et al
    Nodular lesions arising in a large congenital melanocytic nevus in a newborn with eruptive disseminated spitz nevi (nodular lesions arising in a congenital melanocytic nevus and eruptive spitz nevi).
    Br J Dermatol. 2011 Jun 28. doi: 10.1111/j.1365-2133.2011.10502.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    May 2011
86. WALLINGFORD SC , Alston RD, Birch JM, Green AC, et al
    Increases in invasive melanoma in England, 1979-2006, by anatomic site.
    Br J Dermatol. 2011 May 28. doi: 10.1111/j.1365-2133.2011.10434.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
87. DIAZ-CANO SJ
    Paratumoral gene expression profiles: Promising markers of malignancy in melanocytic lesions.
    Br J Dermatol. 2011 May 28. doi: 10.1111/j.1365-2133.2011.10437.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
88. OBA J , Moroi Y, Nakahara T, Abe T, et al
    Title: Expression of milk fat globule epidermal growth factor-VIII may be an indicator of poor prognosis in malignant melanoma.
    Br J Dermatol. 2011 May 17. doi: 10.1111/j.1365-2133.2011.10409.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
89. PARADISI A , Waterboer T, Sampogna F, Tabolli S, et al
    SEROPOSITIVITY FOR HUMAN PAPILLOMAVIRUS AND INCIDENCE OF SUBSEQUENT SQUAMOUS CELL AND BASAL CELL CARCINOMAS OF THE SKIN IN PATIENTS WITH A PREVIOUS NON-MELANOMA SKIN CANCER.
    Br J Dermatol. 2011 May 11. doi: 10.1111/j.1365-2133.2011.10403.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    April 2011
90. SCHOENEWOLF NL , Urosevic-Maiwald M, Dummer R
    Tumor heterogeneity of mucosal melanomas during treatment with imatinib.
    Br J Dermatol. 2011 Apr 18. doi: 10.1111/j.1365-2133.2011.10376.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
91. FUGLEDE NB , Brinck-Claussen UO, Deltour I, Boesen EH, et al
    Incidence of cutaneous malignant melanoma in Denmark, 1978-2007.
    Br J Dermatol. 2011 Apr 5. doi: 10.1111/j.1365-2133.2011.10361.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
92. TENNIS P , Gelfand JM, Rothman KJ
    Evaluation of Cancer Risk Related to Atopic Dermatitis and Use of Topical Calcineurin Inhibitors.
    Br J Dermatol. 2011 Apr 5. doi: 10.1111/j.1365-2133.2011.10363.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
93. BRANDT A , Sundquist J, Hemminki K
    Risk of incident and fatal melanoma in individuals with a family history of incident or fatal melanoma or any cancer.
    Br J Dermatol. 2011 Apr 1. doi: 10.1111/j.1365-2133.2011.10350.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
94. IDORN LW , Philipsen PA, Wulf HC
    Sun exposure before and after a diagnosis of cutaneous malignant melanoma: estimated by developments in serum vitamin D, skin pigmentation and interviews.
    Br J Dermatol. 2011 Apr 1. doi: 10.1111/j.1365-2133.2011.10348.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
95. GRICHNIK JM
    Stratum corneum RNA levels are diagnostic for melanoma.
    Br J Dermatol. 2011;164:693-4.
    PubMed     Text format     Related articles   
    
    
    
    
96. ARGENZIANO G , Catricala C, Ardigo M, Buccini P, et al
    Seven-point checklist of dermoscopy revisited.
    Br J Dermatol. 2011;164:785-90.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    February 2011
97. PAUROBALLY D , Jason F, Dezfoulian B, Nikkels AF, et al
    Melanotan-associated melanoma.
    Br J Dermatol. 2011 Feb 24. doi: 10.1111/j.1365-2133.2011.10273.
    PubMed     Text format     Related articles   
    
    
    
    January 2011
98. TJIU JW , Lin PJ, Wu WH, Cheng YP, et al
    SLURP1 mutation-impaired T-cell activation in a family with mal de Meleda.
    Br J Dermatol. 2011;164:47-53.
    PubMed     Text format     Related articles   
    
    
    
    December 2010
99. AKAY BN , Kocyigit P, Heper AO, Erdem C, et al
    Dermatoscopy of flat pigmented facial lesions: diagnostic challenge between pigmented actinic keratosis and lentigo maligna.
    Br J Dermatol. 2010;163:1212-7.
    PubMed     Text format     Related articles    Abstract available
    
    
    

Thank you for your interest in scientific medicine.

This service is provided by AMEDEO through a media sponsorship by Boehringer Ingelheim.

All AMEDEO services are free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Amedeo is a Flying Publisher website.    Design: